Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Mark, Sorbero"'
Autor:
Olivia K. Golan, Flora Sheng, Andrew W. Dick, Mark Sorbero, Daniel J. Whitaker, Barbara Andraka-Christou, Therese Pigott, Adam J. Gordon, Bradley D. Stein
Publikováno v:
Drug and Alcohol Dependence Reports, Vol 9, Iss , Pp 100193- (2023)
Background: Although use of buprenorphine for treating opioid use disorder increased over the past decade, buprenorphine utilization remains limited in lower-income and rural areas. We examine how the Affordable Care Act Medicaid expansion influenced
Externí odkaz:
https://doaj.org/article/3b9b6016f45a42a6bcb535678e145303
Autor:
Tadeja Gracner, Patricia W. Stone, Mansi Agarwal, Mark Sorbero, Susan L Mitchell, Andrew W. Dick
Publikováno v:
BMC Geriatrics, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Though work has been done studying nursing home (NH) residents with either advanced Alzheimer’s disease (AD) or Alzheimer’s disease related dementia (ADRD), none have distinguished between them; even though their clinical feat
Externí odkaz:
https://doaj.org/article/814fa2bbcbc64a489a91f0175a6d2864
Autor:
Bradley D. Stein, Rachel K. Landis, Flora Sheng, Brendan Saloner, Adam J. Gordon, Mark Sorbero, Andrew W. Dick
Publikováno v:
Journal of General Internal Medicine. 38:733-737
During the COVID pandemic, overall buprenorphine treatment appeared to remain relatively stable, despite some studies suggesting a decrease in patients starting buprenorphine. There is a paucity of empirical information regarding patterns of buprenor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24d11e425c48f02539b1a2e2303fdcc9
https://doi.org/10.1007/s11606-022-07891-w
https://doi.org/10.1007/s11606-022-07891-w
Publikováno v:
Ann Emerg Med
STUDY OBJECTIVE: Buprenorphine treatment for opioid use disorder provided in the emergency department with subsequent buprenorphine treatment by community prescribers is associated with improved outcomes, but the frequency with which this occurs is u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0e7669e76b82e2b9e136b9efac8e207
https://doi.org/10.1016/j.annemergmed.2022.01.042
https://doi.org/10.1016/j.annemergmed.2022.01.042
Autor:
Rachel K. Landis, Jonathan S. Levin, Brendan Saloner, Adam J. Gordon, Andrew W. Dick, Tisamarie B. Sherry, Douglas L. Leslie, Mark Sorbero, Bradley D. Stein
Publikováno v:
Substance Abuse. 43:1057-1071
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da64d14d1a0fcd5fc13ef0a3f8b22501
https://doi.org/10.1080/08897077.2022.2060424
https://doi.org/10.1080/08897077.2022.2060424
Publikováno v:
Medical Care Research and Review. 79:789-797
Nurse practitioner (NP) and physician assistant (PA) prescribing can increase access to buprenorphine treatment for opioid use disorder. In this cross-sectional study, we used deidentified claims from approximately 90% of U.S. retail pharmacies (2017
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84974cd54fae045d9b2b3596f4d19d9d
https://doi.org/10.1177/10775587221086489
https://doi.org/10.1177/10775587221086489
Autor:
Ashley M. Kranz, Isaac M. Opper, Bradley D. Stein, Teague Ruder, Grace Gahlon, Mark Sorbero, Andrew W. Dick
Publikováno v:
Medical Care Research and Review. 79:834-843
All Medicaid programs pay for fluoride varnish applications during medical visits for infants and toddlers, but receipt of care varies considerably across states. Using 2006–2014 Medicaid data from 22 states, this study examined the association bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4377808ced88c6e467aae693eec6294c
https://doi.org/10.1177/10775587221074766
https://doi.org/10.1177/10775587221074766
Autor:
Rachel K. Landis, Isaac Opper, Brendan Saloner, Adam J. Gordon, Douglas L. Leslie, Mark Sorbero, Bradley D. Stein
Publikováno v:
Drug and alcohol dependence. 241
Buprenorphine is an effective medication for the treatment of opioid use disorder (OUD), but the association between prior authorization policies and quality of care for individuals receiving buprenorphine treatment is not well-understood.Using 2006-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c005a07764aeba64efa99d7aadd651b
https://pubmed.ncbi.nlm.nih.gov/36332589
https://pubmed.ncbi.nlm.nih.gov/36332589
Autor:
Bradley D. Stein, Flora Sheng, Erin A. Taylor, Andrew W. Dick, Mark Sorbero, Rosalie Liccardo Pacula
Publikováno v:
Drug Alcohol Depend
BACKGROUND: Multiple state policies, such as prescription drug monitoring programs (PDMPs) and duration limits, have been implemented to decrease high-risk opioid prescribing. Studies demonstrate that many policies decrease certain opioid prescribing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5feae8cb41501352d285788d3dbc288d
https://europepmc.org/articles/PMC8810626/
https://europepmc.org/articles/PMC8810626/
Publikováno v:
Ann Intern Med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ac268b4476d5902138e3caddc9fd706
https://pubmed.ncbi.nlm.nih.gov/34958601
https://pubmed.ncbi.nlm.nih.gov/34958601